Oncology Corporate Profile
Belrose Pharma Inc. is a privately-held clinical-stage biopharmaceutical company focused on the development of new treatments for orphan diseases and other conditions with high unmet medical needs. Belrose Pharma currently has two Phase 2/3 clinical programs and two additional earlier stage candidates with the potential for accelerated approval based on an abbreviated approval pathway.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|BEL-0222||angiogenesis inhibitor||Breast cancer||II|
|PEG-SN38||angiogenesis inhibitor||Breast cancer||II|
|PEG-SN38||angiogenesis inhibitor||Pediatric Neuroblastoma||I|
View additional information on product candidates here »